scri.com
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development.
👤 Joined on 15 January 2025
Followers
Following
Total Posts
@scrinetwork.bsky.social@scrinetwork.bsky.social → @scri.comMeredith McKean, MD, MPH, of @scri.com, shares commentary on updates to #MerkelCellCarcinoma presented at the #ASCO26, including data on #pembrolizumab, #avelumab, and #tuvusertib. #Dermatology #SkinCancer 📹 Watch the full video here: www.docwirenews.com/post/updates...
Show PostMeredith McKean, MD, MPH, of @scri.com, shares commentary on updates in #melanoma presented at #ASCO26, including data on intralesional #daromun and #intismeran. #Dermatology 📹 Watch the full video here: www.docwirenews.com/post/updates...
Show PostAt #ASCO26, join us for Conquering Veteran Cancer, Together — Sun, May 31 | 9:30–11:30 a.m. CT at Hyatt Regency. Proud our CEO Dee Anna Smith is speaking. Register: bmsmeetings.cventevents.com/gqmKoN
Show PostGene therapy is changing lives! For patients with sickle cell disease and beta thalassemia, exa-cel means freedom from hospital visits and a renewed quality of life. 🔗 Learn more in the press release: https://bit.ly/3HTDvM8 @hfrangoul.bsky.social
Show PostThis was an excellent read!
Show Post